SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 34 filers reported holding SUTRO BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $12,060,000 | +159.0% | 1,200,000 | +100.0% | 0.32% | +19.5% |
| Q2 2020 | $4,656,000 | -23.9% | 600,000 | 0.0% | 0.27% | -27.1% |
| Q1 2020 | $6,120,000 | -7.3% | 600,000 | 0.0% | 0.36% | +8.6% |
| Q4 2019 | $6,600,000 | +21.0% | 600,000 | 0.0% | 0.34% | +17.1% |
| Q3 2019 | $5,454,000 | -20.1% | 600,000 | 0.0% | 0.29% | -9.7% |
| Q2 2019 | $6,828,000 | -0.1% | 600,000 | 0.0% | 0.32% | -6.7% |
| Q1 2019 | $6,834,000 | +26.3% | 600,000 | 0.0% | 0.34% | +32.7% |
| Q4 2018 | $5,412,000 | -39.9% | 600,000 | 0.0% | 0.26% | -33.2% |
| Q3 2018 | $9,000,000 | – | 600,000 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
| AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
| Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
| First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
| BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
| Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
| Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
| Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
| Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |